Committing the Oldest Sins in the Newest Kind of Ways—Antibodies Targeting the Influenza Virus Type A Hemagglutinin Globular Head
Author:
- 19 September 2014
- journal article
- review article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 2 (5) , 209-219
Abstract
The globular head of the trimeric influenza hemagglutinin (HA) contains the receptor-binding domain (RBD) and is the target of potently neutralizing human monoclonal antibodies (mAbs) with high in vivo activity. In general, these mAbs are induced easily by vaccination, but only infrequently display cross-neutralizing activity against antigenic drift variants or even against HA molecules from viruses of heterologous subtypes. Recently, the atomic resolution structures of several such antibodies in complex with HA have been determined by X-ray crystallography. Not surprisingly, cross-reactive globular head antibodies target, at least partially, the conserved RBD. The cross-reactive potential of such mAbs is limited by contacts of hypervariable HA residues outside the conserved RBD. The RBD of H2 HA seems especially immunogenic. Increasing the immunogenicity of the RBD of other HA subtypes may be a step toward a universal influenza vaccine. The germ line-encoded Phe54 residue of the CDR-H2 of the V H 1-69 germ line sequence appears to be ideally suited not only to reach into a conserved, hydrophobic pocket on the HA stem, but also to reach into the conserved, hydrophobic pocket that is the RBD. We have cloned antibodies from different individuals that are encoded by the V H 1-69 germ line gene segment that contact the universally conserved Trp153 on the bottom of the RBD. These antibodies serve as further evidence of antibody genetic sequence convergence across individuals.Keywords
This publication has 55 references indexed in Scilit:
- Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibodyProceedings of the National Academy of Sciences, 2012
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityProceedings of the National Academy of Sciences, 2012
- Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencingNature Biotechnology, 2012
- B-cell–lineage immunogen design in vaccine development with HIV-1 as a case studyNature Biotechnology, 2012
- Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininProceedings of the National Academy of Sciences, 2011
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionJournal of Experimental Medicine, 2011
- Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsNature, 2008
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Variation and infectivity neutralization in influenzaImmunology, 2006
- Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolutionNature, 1981